K M C Speciality Hospitals (India) working capital

·Pharma & HealthChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Per cent unless marked ×
Tap a line for its trendFY24Mar 2024FY23Mar 2023FY22Mar 2022FY21Mar 2021FY20 and earlierAlpha Plus
—32.94×32.18×134.30×
FY20 and earlierEvery year the company has filed comes with Alpha Plus.
—9.27×8.17×4.72×
——94.22×379.13×
——−53.87×−240.11×
—5.31×——
—1.00×1.16×1.17×
1.26×—1.23×2.00×
0.81×—0.78×1.10×
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

KMCSHIL₹149.36

K M C Speciality Hospitals (India) Limited

· Pharma & Health
₹ CrorePeersDRAGARWQKOVAILOTUSEYEGPTHEALTHGKSLSHALBYINDRAMEDCOARTEMISMEDMcap ₹2,439 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY21
31/03/2021
FY22
31/03/2022
FY23
31/03/2023
FY24
31/03/2024
Inventory Days (DIO)134.3032.1832.94—
Receivable Days (DSO)4.728.179.27—
Payable Days (DPO)379.1394.22——
Cash Conversion Cycle (days)-240.11-53.87——
Working Capital Turnover——5.31—
Asset Turnover1.171.161.00—
Cash Conversion (CFO/Net Income)2.001.23—1.26
CFO/EBITDA1.100.78—0.81
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY24 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 85%.